← All trials
NCT04306692
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 3, 2020
- Primary completion
- Dec 31, 2020
- Completion date
- Jul 1, 2021
- First posted
- Mar 13, 2020
- Last posted
- Mar 13, 2020
- Enrollment
- 320
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Ghent UniversityLead sponsor
- Gedeon Richter Ltd.Collaborator
- University of AntwerpCollaborator
- AZ Jan Palfijn GentCollaborator
- Our Lady of Lourdes Hospital WaregemCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.